Saluda Medical · 2 weeks ago
Clinical Specialist - Oklahoma City, OK
Saluda Medical is the pioneer in closed-loop Spinal Cord Stimulation (SCS), a ground-breaking SCS therapy that can measure the spinal cord’s response to stimulation and make real-time adjustments to therapy. The Clinical Specialist is responsible for primary clinical support in assisting sales representatives to develop new sales opportunities and accounts with physician and hospital accounts.
Health CareMedicalMedical DeviceNeuroscienceTherapeutics
Responsibilities
Develop and maintain relationships with physicians and staff at assigned clinical sites by providing a high level of service and responsiveness by providing ongoing education and clinical expertise regarding the use of the company’s products
Possess and share superior clinical knowledge of the Company’s products, their clinical applications, instructions for use and procedural techniques
Provide technical and educational training to physicians and staff on the use of the company’s products
Provide case support, including Operating Room/Procedure support
Work with sales, marketing, and R & D personnel to communicate product, clinical and market information to appropriate Saluda personnel to support and develop product improvements
Serve as primary resource for clinical support including, but not limited to: troubleshooting, programming, and patient follow-up for company products
Perform patient follow-up to assure customer and patient success with the implanted products
Develop and maintain business relationships with hospital personnel
Visit customers and patients in a clinical environment (hospitals, operating rooms, clinics and surgical centers)
Qualification
Required
Bachelor's degree or equivalent combination of education and experience
3+ years of experience in a clinical or hospital environment
3+ years of experience in implantable medical devices
Operating room experience
Company
Saluda Medical
Saluda Medical is a commercial-stage medical device company that develops treatments for chronic neurological conditions.
Funding
Current Stage
Public CompanyTotal Funding
$529.53MKey Investors
Redmile GroupWellington ManagementMedtronic
2025-12-05IPO
2025-11-12Undisclosed· $30M
2025-01-10Series Unknown· $100M
Recent News
2025-12-22
2025-12-09
Company data provided by crunchbase